A carregar...
Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy
INTRODUCTION: The benefit of annual administration of zoledronic acid in the management of thalassemia-associated osteoporosis is unknown. AIM: The aims of this study were to evaluate the efficacy of treatment with two different dosing regimens of IV zoledronic acid (annually versus every 3 months)...
Na minha lista:
| Publicado no: | Med Arch |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Academy of Medical Sciences of Bosnia and Herzegovina
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021158/ https://ncbi.nlm.nih.gov/pubmed/30061760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5455/medarh.2018.72.170-173 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|